Adjunctive treatments in pediatric acute respiratory distress syndrome

References

• Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342(18):1334-49
   PubMed Web of Science ®Google Scholar
• Tomashefski JF Jr. Pulmonary pathology of the adult respiratory distress syndrome. Clin Chest Med 1990;11(4):593-619
   PubMed Web of Science ®Google Scholar
• Park WY, Goodman RB, Steinberg KP, et al. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;164(10 Pt 1):1896-903
   PubMed Web of Science ®Google Scholar
• Goodman RB, Strieter RM, Martin DP, et al. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1996;154(3 Pt 1):602-11
   PubMedGoogle Scholar
• Steinberg KP, Milberg JA, Martin TR, et al. Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am J Respir Crit Care Med 1994;150(1):113-22
   PubMedGoogle Scholar
• Lopez-Fernandez Y, Azagra AM, de la Oliva P, et al. Pediatric acute lung injury epidemiology and natural history study: incidence and outcome of the acute respiratory distress syndrome in children. Crit Care Med 2012;40(12):3238-45
   Google Scholar
• Erickson S, Schibler A, Numa A, et al. Acute lung injury in pediatric intensive care in Australia and New Zealand: a prospective, multicenter, observational study. Pediatr Crit Care Med 2007;8(4):317-23
   Web of Science ®Google Scholar
• Flori HR, Glidden DV, Rutherford GW, Matthay MA. Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality. Am J Respir Crit Care Med 2005;171(9):995-1001
   Google Scholar
• Zimmerman JJ, Akhtar SR, Caldwell E, Rubenfeld GD. Incidence and outcomes of pediatric acute lung injury. Pediatrics 2009;124(1):87-95
   PubMed Web of Science ®Google Scholar
• Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149(3 Pt 1):818-24
   PubMed Web of Science ®Google Scholar
• Ferguson ND, Fan E, Camporota L, et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med 2012;38(10):1573-82
   PubMed Web of Science ®Google Scholar
• De Luca D, Piastra M, Chidini G, et al. The use of the Berlin definition for acute respiratory distress syndrome during infancy and early childhood: multicenter evaluation and expert consensus. Intensive Care Med 2013;39(12):2083-91
   PubMed Web of Science ®Google Scholar
• Santschi M, Randolph AG, Rimensberger PC, Jouvet P. Mechanical ventilation strategies in children with acute lung injury: a survey on stated practice pattern*. Pediatr Crit Care Med 2013;14(7):e332-7
   Google Scholar
• Piehl MA, Brown RS. Use of extreme position changes in acute respiratory failure. Crit Care Med 1976;4(1):13-14
   PubMed Web of Science ®Google Scholar
• Pappert D, Rossaint R, Slama K, et al. Influence of positioning on ventilation-perfusion relationships in severe adult respiratory distress syndrome. Chest 1994;106(5):1511-16
   Google Scholar
• Pelosi P, Tubiolo D, Mascheroni D, et al. Effects of the prone position on respiratory mechanics and gas exchange during acute lung injury. Am J Respir Crit Care Med 1998;157(2):387-93
   PubMed Web of Science ®Google Scholar
• Pelosi P, Croci M, Calappi E, et al. The prone positioning during general anesthesia minimally affects respiratory mechanics while improving functional residual capacity and increasing oxygen tension. Anesth Analg 1995;80(5):955-60
   PubMed Web of Science ®Google Scholar
• Numa AH, Hammer J, Newth CJ. Effect of prone and supine positions on functional residual capacity, oxygenation, and respiratory mechanics in ventilated infants and children. Am J Respir Crit Care Med 1997;156(4 Pt 1):1185-9
   Google Scholar
• Douglas WW, Rehder K, Beynen FM, et al. Improved oxygenation in patients with acute respiratory failure: the prone position. Am Rev Respir Dis 1977;115(4):559-66
   PubMed Web of Science ®Google Scholar
• Wagaman MJ, Shutack JG, Moomjian AS, et al. Improved oxygenation and lung compliance with prone positioning of neonates. J Pediatr 1979;94(5):787-91
   PubMed Web of Science ®Google Scholar
• Pelosi P, D’Andrea L, Vitale G, et al. Vertical gradient of regional lung inflation in adult respiratory distress syndrome. Am J Respir Crit Care Med 1994;149(1):8-13
   PubMed Web of Science ®Google Scholar
• Froese AB, Bryan AC. Effects of anesthesia and paralysis on diaphragmatic mechanics in man. Anesthesiology 1974;41(3):242-55
   PubMed Web of Science ®Google Scholar
• Lamm WJ, Graham MM, Albert RK. Mechanism by which the prone position improves oxygenation in acute lung injury. Am J Respir Crit Care Med 1994;150(1):184-93
   PubMed Web of Science ®Google Scholar
• Gattinoni L, Pelosi P, Vitale G, et al. Body position changes redistribute lung computed-tomographic density in patients with acute respiratory failure. Anesthesiology 1991;74(1):15-23
   Google Scholar
• Mure M, Domino KB, Lindahl SG, et al. Regional ventilation-perfusion distribution is more uniform in the prone position. J Appl Physiol (1985) 2000:88(3):1076-83
   Google Scholar
• Gattinoni L, Tognoni G, Pesenti A, et al. Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med 2001;345(8):568-73
   PubMed Web of Science ®Google Scholar
• Gattinoni L, Vagginelli F, Carlesso E, et al. Decrease in Paco2 with prone position is predictive of improved outcome in acute respiratory distress syndrome. Crit Care Med 2003;31(12):2727-33
   PubMed Web of Science ®Google Scholar
• Guerin C, Gaillard S, Lemasson S, et al. Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial. JAMA 2004;292(19):2379-87
   PubMed Web of Science ®Google Scholar
• Taccone P, Pesenti A, Latini R, et al. Prone positioning in patients with moderate and severe acute respiratory distress syndrome: a randomized controlled trial. JAMA 2009;302(18):1977-84
   PubMed Web of Science ®Google Scholar
• Casado-Flores J, Martinez de Azagra A, Ruiz-Lopez MJ, et al. Pediatric ARDS: effect of supine-prone postural changes on oxygenation. Intensive Care Med 2002;28(12):1792-6
   Google Scholar
• Sud S, Sud M, Friedrich JO, Adhikari NK. Effect of mechanical ventilation in the prone position on clinical outcomes in patients with acute hypoxemic respiratory failure: a systematic review and meta-analysis. CMAJ 2008;178(9):1153-61
   Google Scholar
• Guerin C, Reignier J, Richard JC, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013;368(23):2159-68
   PubMed Web of Science ®Google Scholar
• Gattinoni L, Pesenti A, Carlesso E. Body position changes redistribute lung computed-tomographic density in patients with acute respiratory failure: impact and clinical fallout through the following 20 years. Intensive Care Med 2013;39(11):1909-15
   Google Scholar
• Gattinoni L, Taccone P, Carlesso E, Marini JJ. Prone position in acute respiratory distress syndrome. Rationale, indications, and limits. Am J Respir Crit Care Med 2013;188(11):1286-93
   PubMed Web of Science ®Google Scholar
• Bancalari E, Clausen J. Pathophysiology of changes in absolute lung volumes. Eur Respir J 1998;12(1):248-58
   PubMed Web of Science ®Google Scholar
• von Ungern-Sternberg BS, Hammer J, Frei FJ, et al. Prone equals prone? Impact of positioning techniques on respiratory function in anesthetized and paralyzed healthy children. Intensive Care Med 2007;33(10):1771-7
   PubMed Web of Science ®Google Scholar
• Curley MA, Hibberd PL, Fineman LD, et al. Effect of prone positioning on clinical outcomes in children with acute lung injury: a randomized controlled trial. JAMA 2005;294(2):229-37
   Google Scholar
• Gillies D, Wells D, Bhandari AP. Positioning for acute respiratory distress in hospitalised infants and children. Cochrane Database Syst Rev 2012;7:CD003645
   Google Scholar
• Relvas MS, Silver PC, Sagy M. Prone positioning of pediatric patients with ARDS results in improvement in oxygenation if maintained > 12 h daily. Chest 2003;124(1):269-74
   Google Scholar
• Goettler CE, Pryor JP, Reilly PM. Brachial plexopathy after prone positioning. Crit Care 2002;6(6):540-2
   Google Scholar
• Kaisers U, Busch T, Deja M, et al. Selective pulmonary vasodilation in acute respiratory distress syndrome. Crit Care Med 2003;31(4):S337-42
   Google Scholar
• Villar J, Blazquez MA, Lubillo S, et al. Pulmonary hypertension in acute respiratory failure. Crit Care Med 1989;17(6):523-6
   Google Scholar
• Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333(6174):664-6
   PubMed Web of Science ®Google Scholar
• Dellinger RP, Zimmerman JL, Taylor RW, et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med 1998;26(1):15-23
   PubMed Web of Science ®Google Scholar
• Rossaint R, Falke KJ, Lopez F, et al. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328(6):399-405
   PubMed Web of Science ®Google Scholar
• Clark RH, Kueser TJ, Walker MW, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med 2000;342(7):469-74
   PubMed Web of Science ®Google Scholar
• Davidson D, Barefield ES, Kattwinkel J, et al. The I-NO/PPHN Study Group. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. Pediatrics 1998;101(3 Pt 1):325-34
   Google Scholar
• Miller OI, Tang SF, Keech A, et al. Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study. Lancet 2000;356(9240):1464-9
   PubMed Web of Science ®Google Scholar
• Solina A, Papp D, Ginsberg S, et al. A comparison of inhaled nitric oxide and milrinone for the treatment of pulmonary hypertension in adult cardiac surgery patients. J Cardiothorac Vasc Anesth 2000;14(1):12-17
   Google Scholar
• Tang SF, Sherwood MC, Miller OI. Randomised trial of three doses of inhaled nitric oxide in acute respiratory distress syndrome. Arch Dis Child 1998;79(5):415-18
   PubMed Web of Science ®Google Scholar
• Lundin S, Mang H, Smithies M, et al. Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide. Intensive Care Med 1999;25(9):911-19
   PubMed Web of Science ®Google Scholar
• Okamoto K, Hamaguchi M, Kukita I, et al. Efficacy of inhaled nitric oxide in children with ARDS. Chest 1998;114(3):827-33
   Google Scholar
• Demirakca S, Dotsch J, Knothe C, et al. Inhaled nitric oxide in neonatal and pediatric acute respiratory distress syndrome: dose response, prolonged inhalation, and weaning. Crit Care Med 1996;24(11):1913-19
   PubMedGoogle Scholar
• Rossaint R, Gerlach H, Schmidt-Ruhnke H, et al. Efficacy of inhaled nitric oxide in patients with severe ARDS. Chest 1995;107(4):1107-15
   Google Scholar
• Abman SH, Griebel JL, Parker DK, et al. Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure. J Pediatr 1994;124(6):881-8
   PubMed Web of Science ®Google Scholar
• Germann P, Poschl G, Leitner C, et al. Additive effect of nitric oxide inhalation on the oxygenation benefit of the prone position in the adult respiratory distress syndrome. Anesthesiology 1998;89(6):1401-6
   Google Scholar
• Johannigman JA, Davis K Jr, Miller SL, et al. Prone positioning and inhaled nitric oxide: synergistic therapies for acute respiratory distress syndrome. J Trauma 2001;50(4):589-95; discussion 595-586
   PubMed Web of Science ®Google Scholar
• Johannigman JA, Davis K Jr, Campbell RS, et al. Positive end-expiratory pressure and response to inhaled nitric oxide: changing nonresponders to responders. Surgery 2000;127(4):390-4
   Google Scholar
• Okamoto K, Kukita I, Hamaguchi M, et al. Combined effects of inhaled nitric oxide and positive end-expiratory pressure during mechanical ventilation in acute respiratory distress syndrome. Artif Organs 2000;24(5):390-5
   Google Scholar
• Dobyns EL, Anas NG, Fortenberry JD, et al. Interactive effects of high-frequency oscillatory ventilation and inhaled nitric oxide in acute hypoxemic respiratory failure in pediatrics. Crit Care Med 2002;30(11):2425-9
   PubMed Web of Science ®Google Scholar
• Krafft P, Fridrich P, Fitzgerald RD, et al. Effectiveness of nitric oxide inhalation in septic ARDS. Chest 1996;109(2):486-93
   Google Scholar
• Manktelow C, Bigatello LM, Hess D, Hurford WE. Physiologic determinants of the response to inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology 1997;87(2):297-307
   Web of Science ®Google Scholar
• Dobyns EL, Cornfield DN, Anas NG, et al. Multicenter randomized controlled trial of the effects of inhaled nitric oxide therapy on gas exchange in children with acute hypoxemic respiratory failure. J Pediatr 1999;134(4):406-12
   PubMed Web of Science ®Google Scholar
• Taylor RW, Zimmerman JL, Dellinger RP, et al. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA 2004;291(13):1603-9
   PubMed Web of Science ®Google Scholar
• Adhikari NK, Burns KE, Friedrich JO, et al. Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ 2007;334(7597):779
   PubMed Web of Science ®Google Scholar
• Cueto E, Lopez-Herce J, Sanchez A, Carrillo A. Life-threatening effects of discontinuing inhaled nitric oxide in children. Acta Paediatr 1997;86(12):1337-9
   PubMed Web of Science ®Google Scholar
• Afshari A, Brok J, Moller AM, Wetterslev J. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) and acute lung injury in children and adults. Cochrane Database Syst Rev 2010(7):CD002787
   Google Scholar
• Vane JR, Botting RM. Regulatory mechanisms of the vascular endothelium: an update. Pol J Pharmacol 1994;46(6):499-21
   Google Scholar
• Tateson JE, Moncada S, Vane JR. Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets. Prostaglandins 1977;13(3):389-97
   Google Scholar
• Krishnan U. Management of pulmonary arterial hypertension in the neonatal unit. Cardiol Rev 2010;18(2):73-5
   Google Scholar
• Ivy DD. Prostacyclin in the intensive care setting. Pediatr Crit Care Med 2010;11(Suppl 2):S41-5
   Google Scholar
• McLaughlin VV, Palevsky HI. Parenteral and inhaled prostanoid therapy in the treatment of pulmonary arterial hypertension. Clin Chest Med 2013;34(4):825-40
   PubMed Web of Science ®Google Scholar
• Walmrath D, Schneider T, Pilch J, et al. Aerosolised prostacyclin in adult respiratory distress syndrome. Lancet 1993;342(8877):961-2
   PubMed Web of Science ®Google Scholar
• Walmrath D, Schneider T, Schermuly R, et al. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am J Respir Crit Care Med 1996;153(3):991-6
   PubMed Web of Science ®Google Scholar
• Pappert D, Busch T, Gerlach H, et al. Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome. Anesthesiology 1995;82(6):1507-11
   PubMed Web of Science ®Google Scholar
• van Heerden PV, Barden A, Michalopoulos N, et al. Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS. Chest 2000;117(3):819-27
   PubMed Web of Science ®Google Scholar
• Dahlem P, van Aalderen WM, de Neef M, et al. Randomized controlled trial of aerosolized prostacyclin therapy in children with acute lung injury. Crit Care Med 2004;32(4):1055-60
   PubMed Web of Science ®Google Scholar
• Afshari A, Brok J, Moller AM, Wetterslev J. Aerosolized prostacyclin for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Cochrane Database Syst Rev 2010(8):CD007733
   Google Scholar
• Bone RC, Slotman G, Maunder R, et al. Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Prostaglandin E1 Study Group. Chest 1989;96(1):114-19
   Google Scholar
• Abraham E, Baughman R, Fletcher E, et al. TLC C-53 ARDS Study Group. Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. Crit Care Med 1999;27(8):1478-85
   PubMed Web of Science ®Google Scholar
• Vincent JL, Brase R, Santman F, et al. A multi-centre, double-blind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome. Intensive Care Med 2001;27(10):1578-83
   PubMed Web of Science ®Google Scholar
• MacIntyre NR, Silver RM, Miller CW, et al. Aerosol delivery in intubated, mechanically ventilated patients. Crit Care Med 1985;13(2):81-4
   PubMed Web of Science ®Google Scholar
• Blitzer ML, Loh E, Roddy MA, et al. Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans. J Am Coll Cardiol 1996;28(3):591-6
   Google Scholar
• Stamler JS, Loh E, Roddy MA, et al. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 1994;89(5):2035-40
   Google Scholar
• Ghofrani HA, Reichenberger F, Kohstall MG, et al. Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial. Ann Intern Med 2004;141(3):169-77
   PubMed Web of Science ®Google Scholar
• Galie N, Ghofrani HA, Torbicki A, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005;353(20):2148-57
   PubMed Web of Science ®Google Scholar
• Shah PS, Ohlsson A. Sildenafil for pulmonary hypertension in neonates. Cochrane Database Syst Rev 2011(8):CD005494
   Google Scholar
• Barst RJ, Ivy DD, Gaitan G, et al. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension. Circulation 2012;125(2):324-34
   PubMed Web of Science ®Google Scholar
• Cornet AD, Hofstra JJ, Swart EL, et al. Sildenafil attenuates pulmonary arterial pressure but does not improve oxygenation during ARDS. Intensive Care Med 2010;36(5):758-64
   Google Scholar
• Namachivayam P, Theilen U, Butt WW, et al. Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children. Am J Respir Crit Care Med 2006;174(9):1042-7
   PubMed Web of Science ®Google Scholar
• Giacomini M, Borotto E, Bosotti L, et al. Vardenafil and weaning from inhaled nitric oxide: effect on pulmonary hypertension in ARDS. Anaesth Intensive Care 2007;35(1):91-3
   Google Scholar
• Huddleston AJ, Knoderer CA, Morris JL, Ebenroth ES. Sildenafil for the treatment of pulmonary hypertension in pediatric patients. Pediatr Cardiol 2009;30(7):871-82
   Google Scholar
• Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;163(6):1376-83
   PubMed Web of Science ®Google Scholar
• Matthay MA. Alveolar fluid clearance in patients with ARDS: does it make a difference? Chest 2002;122(Suppl 6):340S-3S
   Google Scholar
• Perkins GD, Gao F, Thickett DR. In vivo and in vitro effects of salbutamol on alveolar epithelial repair in acute lung injury. Thorax 2008;63(3):215-20
   PubMed Web of Science ®Google Scholar
• McAuley DF, Frank JA, Fang X, Matthay MA. Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury. Crit Care Med 2004;32(7):1470-6
   PubMed Web of Science ®Google Scholar
• Perkins GD, McAuley DF, Thickett DR, Gao F. The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006;173(3):281-7
   PubMed Web of Science ®Google Scholar
• Gao Smith F, Perkins GD, Gates S, et al. Effect of intravenous beta-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 2012;379(9812):229-35
   PubMed Web of Science ®Google Scholar
• Chang LH, Honiden S, Haithcock JA, et al. Utilization of bronchodilators in ventilated patients without obstructive airways disease. Respir Care 2007;52(2):154-8
   Google Scholar
• Ballard J, Lugo RA, Salyer JW. A survey of albuterol administration practices in intubated patients in the neonatal intensive care unit. Respir Care 2002;47(1):31-8
   Google Scholar
• Matthay MA, Brower RG, Carson S, et al. Randomized, placebo-controlled clinical trial of an aerosolized beta(2)-agonist for treatment of acute lung injury. Am J Respir Crit Care Med 2011;184(5):561-8
   PubMed Web of Science ®Google Scholar
• Bernard GR, Luce JM, Sprung CL, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987;317(25):1565-70
   PubMed Web of Science ®Google Scholar
• Weigelt JA, Norcross JF, Borman KR, Snyder WH 3rd. Early steroid therapy for respiratory failure. Arch Surg 1985;120(5):536-40
   PubMed Web of Science ®Google Scholar
• Bone RC, Fisher CJ Jr, Clemmer TP, et al. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest 1987;92(6):1032-6
   PubMed Web of Science ®Google Scholar
• Henzen C, Suter A, Lerch E, et al. Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet 2000;355(9203):542-5
   PubMed Web of Science ®Google Scholar
• Thompson BT. Glucocorticoids and acute lung injury. Crit Care Med 2003;31(4):S253-7
   Google Scholar
• Steinberg KP, Hudson LD, Goodman RB, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006;354(16):1671-84
   PubMed Web of Science ®Google Scholar
• Meduri GU, Marik PE, Chrousos GP, et al. Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med 2008;34(1):61-9
   PubMed Web of Science ®Google Scholar
• Meduri GU, Headley AS, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998;280(2):159-65
   PubMed Web of Science ®Google Scholar
• Meduri GU, Golden E, Freire AX, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007;131(4):954-63
   PubMed Web of Science ®Google Scholar
• Peter JV, John P, Graham PL, et al. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ 2008;336(7651):1006-9
   PubMed Web of Science ®Google Scholar
• Goh AY, Sekaran D, Roziah M. Corticosteroid rescue in late paediatric acute respiratory distress syndrome. Respirology 1999;4(3):295-7
   PubMedGoogle Scholar
• Martinot A, Fourier C, Cremer R, et al. Short-course, high-dose corticosteroid treatment in six children with late ARDS. Pediatr Pulmonol 1997;23(4):314-16
   PubMed Web of Science ®Google Scholar
• Guglani L, Jain S, Lodha R. Methylprednisolone therapy in a child with unresolving ARDS. Indian Pediatr 2006;43(7):639-42
   PubMed Web of Science ®Google Scholar
• Annane D, Sebille V, Bellissant E. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med 2006;34(1):22-30
   PubMed Web of Science ®Google Scholar
• Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008;36(6):1937-49
   PubMed Web of Science ®Google Scholar
• Marik PE, Meduri GU, Rocco PR, Annane D. Glucocorticoid treatment in acute lung injury and acute respiratory distress syndrome. Crit Care Clin 2011;27(3):589-607
   Google Scholar
• Enhorning G, Shumel B, Keicher L, et al. Phospholipases introduced into the hypophase affect the surfactant film outlining a bubble. J Appl Physiol (1985) 1992;73(3):941-5
   Google Scholar
• Holm BA, Enhorning G, Notter RH. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem Phys Lipids 1988;49(1-2):49-55
   Google Scholar
• Holm BA, Keicher L, Liu MY, et al. Inhibition of pulmonary surfactant function by phospholipases. J Appl Physiol (1985) 1991:71(1):317.321
   Google Scholar
• Holm BA, Matalon S, Finkelstein JN, Notter RH. Type II pneumocyte changes during hyperoxic lung injury and recovery. J Appl Physiol (1985) 1988:65(6):2672-8
   Google Scholar
• Holm BA, Notter RH. Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity. J Appl Physiol (1985) 1987;63(4):1434-42
   PubMed Web of Science ®Google Scholar
• Moses D, Holm BA, Spitale P, et al. Inhibition of pulmonary surfactant function by meconium. Am J Obstet Gynecol 1991;164(2):477-81
   Google Scholar
• Novotny WE, Hudak BB, Matalon S, Holm BA. Hyperoxic lung injury reduces exogenous surfactant clearance in vivo. Am J Respir Crit Care Med 1995;151(6):1843-7
   Google Scholar
• Schmidt R, Markart P, Ruppert C, et al. Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration. Respir Res 2007;8:55
   Google Scholar
• Mastropietro CW, Valentine K. Early administration of intratracheal surfactant (calfactant) after hydrocarbon aspiration. Pediatrics 2011;127(6):e1600-4
   Google Scholar
• Volchkov VA, Dubrovskaya VF, Serzhanina VA, et al. Effectiveness of correction of bleomycin-induced lung injury by early and late administration of surfactant-BL. Bull Exp Biol Med 2012;152(5):580-2
   Google Scholar
• Hahn S, Choi HJ, Soll R, Dargaville PA. Lung lavage for meconium aspiration syndrome in newborn infants. Cochrane Database Syst Rev 2013;4:CD003486
   Google Scholar
• Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2012;11:CD001456
   PubMed Web of Science ®Google Scholar
• Singh N, Hawley KL, Viswanathan K. Efficacy of porcine versus bovine surfactants for preterm newborns with respiratory distress syndrome: systematic review and meta-analysis. Pediatrics 2011;128(6):e1588-95
   Web of Science ®Google Scholar
• Luchetti M, Ferrero F, Gallini C, et al. Multicenter, randomized, controlled study of porcine surfactant in severe respiratory syncytial virus-induced respiratory failure. Pediatr Crit Care Med 2002;3(3):261-8
   PubMedGoogle Scholar
• Luchetti M, Casiraghi G, Valsecchi R, et al. Porcine-derived surfactant treatment of severe bronchiolitis. Acta Anaesthesiol Scand 1998;42(7):805-10
   PubMed Web of Science ®Google Scholar
• Tibby SM, Hatherill M, Wright SM, et al. Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2000;162(4 Pt 1):1251-6
   Google Scholar
• Lewis JF, Brackenbury A. Role of exogenous surfactant in acute lung injury. Crit Care Med 2003;31(4):S324-8
   Google Scholar
• Kesecioglu J, Beale R, Stewart TE, et al. Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2009;180(10):989-94
   PubMed Web of Science ®Google Scholar
• Anzueto A, Baughman RP, Guntupalli KK, et al. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med 1996;334(22):1417-21
   PubMed Web of Science ®Google Scholar
• Willson DF, Thomas NJ, Markovitz BP, et al. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA 2005;293(4):470-6
   PubMed Web of Science ®Google Scholar
• Taut FJ, Rippin G, Schenk P, et al. A Search for subgroups of patients with ARDS who may benefit from surfactant replacement therapy: a pooled analysis of five studies with recombinant surfactant protein-C surfactant (Venticute). Chest 2008;134(4):724-32
   PubMed Web of Science ®Google Scholar
• Spragg RG, Lewis JF, Walmrath HD, et al. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 2004;351(9):884-92
   PubMed Web of Science ®Google Scholar
• Spragg RG, Taut FJ, Lewis JF, et al. Recombinant surfactant protein C-based surfactant for patients with severe direct lung injury. Am J Respir Crit Care Med 2011;183(8):1055-61
   PubMed Web of Science ®Google Scholar
• Hermon MM, Golej J, Burda G, et al. Surfactant therapy in infants and children: three years experience in a pediatric intensive care unit. Shock 2002;17(4):247-51
   Google Scholar
• Yapicioglu H, Yildizdas D, Bayram I, et al. The use of surfactant in children with acute respiratory distress syndrome: efficacy in terms of oxygenation, ventilation and mortality. Pulm Pharmacol Ther 2003;16(6):327-33
   Google Scholar
• Czaja AS. A critical appraisal of a randomized controlled trial: willson, et al: Effect of exogenous surfactant (calfactant) in pediatric acute lung injury (JAMA 2005, 293: 470-476). Pediatr Crit Care Med 2007;8(1):50-3
   Google Scholar
• Duffett M, Choong K, Ng V, et al. Surfactant therapy for acute respiratory failure in children: a systematic review and meta-analysis. Crit Care 2007;11(3):R66
   PubMedGoogle Scholar
• Thomas NJ, Guardia CG, Moya FR, et al. A pilot, randomized, controlled clinical trial of lucinactant, a peptide-containing synthetic surfactant, in infants with acute hypoxemic respiratory failure. Pediatr Crit Care Med 2012;13(6):646-53
   PubMed Web of Science ®Google Scholar
• Willson DF, Thomas NJ, Tamburro R, et al. Pediatric calfactant in acute respiratory distress syndrome trial. Pediatr Crit Care Med 2013;14(7):657-65
   PubMed Web of Science ®Google Scholar
• Zhang LN, Sun JP, Xue XY, Wang JX. Exogenous pulmonary surfactant for acute respiratory distress syndrome in adults: a systematic review and meta-analysis. Exp Ther Med 2013;5(1):237-42
   Web of Science ®Google Scholar
• Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000;342(18):1301-8
   PubMed Web of Science ®Google Scholar
• Randolph AG, Meert KL, O’Neil ME, et al. The feasibility of conducting clinical trials in infants and children with acute respiratory failure. Am J Respir Crit Care Med 2003;167(10):1334-40
   Google Scholar
• Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009;374(9698):1351-63
   PubMed Web of Science ®Google Scholar
• Bein T, Weber-Carstens S, Goldmann A, et al. Lower tidal volume strategy (approximately 3 ml/kg) combined with extracorporeal CO2 removal versus ’conventional’ protective ventilation (6 ml/kg) in severe ARDS: the prospective randomized Xtravent-study. Intensive Care Med 2013;39(5):847-56
   PubMed Web of Science ®Google Scholar
• Trial of Steroids in Pediatric Acute Lung Injury/ARDS. Available from: www.clinicaltrials.gov/ct2/results?term=NCT01274260&Search=Search
   Google Scholar
• Effects and Safety of Infusion of Low-Doses of Methylprednisolone in Early ALI and ARDS in Children. Available from: www.clinicaltrials.gov/ct2/results?term=NCT01757899&Search=Search
   Google Scholar
• United States National Institutes of Health. Available from: www.nih.gov/
   Google Scholar
• Martin R, David JT. Understanding controlled trials: what are pragmatic trials? BMJ 1998;316
   Google Scholar
• Cuthbertson BH, Campbell MK, Stott SA, et al. A pragmatic multi-centre randomised controlled trial of fluid loading in high-risk surgical patients undergoing major elective surgery – the FOCCUS study. Crit Care 2011;15(6):R296
   Google Scholar
• Campbell NL, Khan BA, Farber M, et al. Improving delirium care in the intensive care unit: the design of a pragmatic study. Trials 2011;12:139
   Google Scholar
• Harron K, Lee T, Ball T, et al. Making co-enrolment feasible for randomised controlled trials in paediatric intensive care. PLoS One 2012;7(8):e41791
   Google Scholar
• Santschi M, Jouvet P, Leclerc F, et al. Acute lung injury in children: therapeutic practice and feasibility of international clinical trials. Pediatr Crit Care Med 2010;11(6):681-9
   PubMed Web of Science ®Google Scholar
• Luce JM, Montgomery AB, Marks JD, et al. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 1988;138(1):62-8
   PubMed Web of Science ®Google Scholar